Source: American Journal of Nephrology. Unidade: FM
Subjects: ANGIOTENSINA II, DOENÇA CRÔNICA, EVOLUÇÃO CLÍNICA, MODELOS ANIMAIS
ABNT
FUJIHARA, Clarice Kazue et al. Early Brief Treatment with Losartan plus Mycophenolate Mofetil Provides Lasting Renoprotection in a Renal Ablation Model. American Journal of Nephrology, v. 32, n. 2, p. 95-102, 2010Tradução . . Disponível em: https://doi.org/10.1159/000315137. Acesso em: 03 nov. 2024.APA
Fujihara, C. K., Vieira Jr., J. M., Sena, C. R., Ventura, B. H., Malheiros, D. M., & Zatz, R. (2010). Early Brief Treatment with Losartan plus Mycophenolate Mofetil Provides Lasting Renoprotection in a Renal Ablation Model. American Journal of Nephrology, 32( 2), 95-102. doi:10.1159/000315137NLM
Fujihara CK, Vieira Jr. JM, Sena CR, Ventura BH, Malheiros DM, Zatz R. Early Brief Treatment with Losartan plus Mycophenolate Mofetil Provides Lasting Renoprotection in a Renal Ablation Model [Internet]. American Journal of Nephrology. 2010 ; 32( 2): 95-102.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1159/000315137Vancouver
Fujihara CK, Vieira Jr. JM, Sena CR, Ventura BH, Malheiros DM, Zatz R. Early Brief Treatment with Losartan plus Mycophenolate Mofetil Provides Lasting Renoprotection in a Renal Ablation Model [Internet]. American Journal of Nephrology. 2010 ; 32( 2): 95-102.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1159/000315137